Inadequate Uptake of USPSTF-Recommended Low Dose CT Lung Cancer Screening.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38400557.
- Also identified by DOI 10.1177/21501319241235011 and PMC identifier 10894545.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 2023, <i>Journal of Primary Care and Community Health</i> published the results of 4 outstanding studies in which investigators aimed to explore and improve clinician and eligible individuals' knowledge of the rationale for lung cancer screening (LCS). Their results highlighted the underutilization of LCS, particularly for certain high risk populations, and the continued disparities in screening seen between groups of eligible individuals. Here, key findings from those 2023 <i>Journal of Primary Care and Community Health</i> reports, along with salient findings of other recent LCS reports, are discussed. The bases for the United States Preventive Task Force (USPSTF) LCS recommendations, barriers primary care providers face, the perspective of eligible individuals, importance of shared decision-making (SDM) and disparities between groups in LCS are reviewed along with potential strategies to ensure that more eligible individuals are offered LCS.
Medical subject headings
- Lung Neoplasms